[ Price : $8.95]
A Ropes & Gray year-end review examines significant changes in FDA and Justice Department enforcement actions pertaining to regula...[ Price : $8.95]
FDA lifts a clinical hold on Intellia Therapeutics MAGNITUDE-2 Phase 3 trial evaluating nexiguran ziclumeran for patients with her...[ Price : $8.95]
FDA sends a Warning Letter to Meridian Bioscience over serious quality system violations involving blood lead testing devices manu...[ Price : $8.95]
FDA issues MAST Biosurgery a Warning Letter after an August inspection cited serious manufacturing quality and safety reporting vi...[ Price : $8.95]
FDA approves a Scancell Holdings IND to begin a registrational Phase 3 trial of iSCIB1+ in patients with advanced melanoma.[ Price : $8.95]
A federal judge sentences former CytoDyn chief executive Nader Pourhassan to 30 months in prison for misleading investors about th...[ Price : $8.95]
A Health Affairs analysis on FDAs new pathway allowing drug approvals based on a plausible mechanism of action warns that the appr...[ Price : $8.95]
Sarepta Therapeutics announces that its gene therapy Elevidys significantly slowed disease progression over three years in ambulat...